Neuroinflammation in Parkinson's disease and its potential as therapeutic target.

Wang Q, Liu Y, Zhou J. · 2015

Read Neuroinflammation in Parkinson's disease and its potential as therapeutic target. by Wang Q, Liu Y, Zhou J. (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4603346.txt.

Description

Qian Wang, Ying Liu, and Jiawei Zhou published a 2015 review of inflammation in the brain in Parkinson's disease. The disease kills dopamine neurons in a midbrain region and leaves clumps of a protein called alpha-synuclein. Long-lasting brain inflammation is now seen as part of the process. The review appeared in Translational Neurodegeneration.

Brain immune cells, astrocytes and microglia, stay switched on in patients and release factors that speed neuron loss. Immune cells from outside the brain also enter the affected regions. The authors sum up recent findings on these immune roles and weigh treatment ideas that target inflammation. If inflammation drives part of the damage, calming it could slow a disease that now has no cure.

Catalog record

CREATORWang Q, Liu Y, Zhou J.
YEAR2015
COLLECTIONPAPERS
FORMATTXT
FILE SIZE54 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4603346

Browse the full library · About the Tower of Babel